Clinical Neurosciences

The Clinical Neurosciences CAG is one of the largest centres for neurology, neurosurgery, neurophysiology and neuropsychiatry in the country.

clinical neuro

Our CAG provides world class specialist services in stroke, epilepsy, movement disorders, motor neurone disease and neurofibromatosis. We are national leaders in neuropsychiatry, clinical neuropsychology, functional neurosurgery, paediatric neurosurgery and neuropathology.

Read the latest news from our Clinical Neurosciences CAG. 

We host a large regional neurosciences centre at King’s College Hospital servicing south east London and Kent. We are a national leader in adult and child neurosurgery, and also national leaders in delivering immune modifying therapy to patients with multiple sclerosis. Our child epilepsy surgery service is one of four national centres in England. We are also international leaders in home video telemetry.


The CAG delivers a broad range of highly rated education and training programmes. They include MBBS students, a BSc in Neuroscience, MSc’s in Neuroscience, Clinical Neuroscience and Epilepsy. We have shared postgraduate taught courses with, for example, St Christopher’s Hospice and aMRCP PACES course in neurology at King’s College Hospital. Our four year MSc in Neuroscience launches this year.

Our neurosurgical postgraduate training has been rated as the best large programme in the UK for the last two years, and postgraduate neuroradiology as the best in London over the last two years,


Our CAG has a large portfolio of research network adopted research studies. CLRN: 26 studies (213 patients); Stroke Research Network (SRN): 24 studies ( 414 stroke patients); 38 Pharmaceutical commercial studies (191 patients)

We have 11 FTE clinical-academic staff, more than 50 funded research projects, a grant income of £16.8m, and more than 100 publications.

We provide a world class clinical neurosciences service to our local population and beyond. Our neurosurgery is the most subspecialised and comprehensive in UK. Our brain tumour outcomes (survival) is the best in England and Wales at one year. “We are committed to translating scientific and research discovery into real, tangible treatments for patients and are currently developing a remote monitoring systems in epilepsy and sleep disorder, to monitor patients at home and simultaneously see data from a base hospital and automatically analyse it.
Dr Jozef Jarosz and Professor Mark Richardson, Joint Leads Clinical Neurosciences CAG

Clinical Neurosciences Clinical Academic Group Leaders

Dr Jozef Jarosz, Professor Mark Richardson